229 related articles for article (PubMed ID: 28505188)
1. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
[TBL] [Abstract][Full Text] [Related]
2. The determinants of survival among adults with cystic fibrosis-a cohort study.
Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the progression of cystic fibrosis lung disease throughout childhood.
Sanders DB; Li Z; Laxova A; Rock MJ; Levy H; Collins J; Ferec C; Farrell PM
Ann Am Thorac Soc; 2014 Jan; 11(1):63-72. PubMed ID: 24261460
[TBL] [Abstract][Full Text] [Related]
6. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
[TBL] [Abstract][Full Text] [Related]
7. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
[TBL] [Abstract][Full Text] [Related]
8. Change in lung clearance index with microbiological status in children with cystic fibrosis.
Walicka-Serzysko K; Postek M; Milczewska J; Sands D
Pediatr Pulmonol; 2019 Jun; 54(6):729-736. PubMed ID: 30838817
[TBL] [Abstract][Full Text] [Related]
9. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Dassios TG; Katelari A; Doudounakis S; Dimitriou G
Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
[TBL] [Abstract][Full Text] [Related]
10. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.
Keating CL; Liu X; Dimango EA
Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956
[TBL] [Abstract][Full Text] [Related]
11. Environmental allergies and respiratory morbidities in cystic fibrosis.
Collaco JM; Morrow CB; Green DM; Cutting GR; Mogayzel PJ
Pediatr Pulmonol; 2013 Sep; 48(9):857-64. PubMed ID: 23143815
[TBL] [Abstract][Full Text] [Related]
12. Genetic Association With
Nourkami-Tutdibi N; Freitag K; Zemlin M; Tutdibi E
Front Immunol; 2021; 12():587313. PubMed ID: 33679736
[No Abstract] [Full Text] [Related]
13. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
15. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.
Roussey M; Le Bihannic A; Scotet V; Audrezet MP; Blayau M; Dagorne M; David V; Deneuville E; Giniès JL; Laurans M; Moisan-Petit V; Rault G; Vigneron P; Férec C
J Inherit Metab Dis; 2007 Aug; 30(4):613. PubMed ID: 17632692
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
[TBL] [Abstract][Full Text] [Related]
18. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
[TBL] [Abstract][Full Text] [Related]
20. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.
Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D
Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]